Eaton Vance Management Staar Surgical CO Transaction History

Eaton Vance Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$50.24 - $80.48 $612,124 - $980,568	-12,184 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.98 - $93.5 $704,109 - $1.14 Million	12,144 Added 30360.0%	12,184 $973,000
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $1,760 - $2,555	20 Added 100.0%	40 $1,000
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $5,646 - $7,483	-46 Reduced 69.7%	20 $1,000
Q2 2021 Aug 16, 2021	SELL	$105.76 - $154.96 $55,418 - $81,199	-524 Reduced 88.81%	66 $10,000
Q1 2021 May 17, 2021	BUY	$78.5 - $126.48 $46,315 - $74,623	590 New	590 $62,000

245

47.2M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.12B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.